BMAL1 and depressive disorder: We demonstrate here that the administration of the synthetic REV-ERB agonist SR1006732 causes a transient anhedonic effect in DD conditions and enhances the development and maintenance of stress-induced depression-like phenotype in the CDM in LD, whilst suppressing Bmal1 and Homer1a expression.